NCT05785780
Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings
Enrolling by Invitation
NAAges 50–74InterventionalHealth servicesRutgers, The State University of New JerseyInvestigator-initiated
~30 participants
Updated 2026-07-10 on ClinicalTrials.gov
What's tested:Targeted CRC Screening Toolkit
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Colonoscopy uptake
Measured over 12 months
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesNew Jersey1
Study leadership
- Denalee O'Malley, PhD · PRINCIPAL_INVESTIGATOR · Rutgers Robert Wood Johnson Medical School; Rutgers Cancer Institute of New Jersey
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Diagnosis of diabetes mellitus;
Participants not up-to-date with CRC screening based on electronic health record (e.g. FOBT/FIT in last year; flexible sigmoidoscopy within four years; or colonoscopy within nine years);
Age-eligible for CRC screening (50-74 years of age);
Participants in process of undergoing screening are eligible for participation if they have a FIT/FOBT incomplete test ordered for more than six months or a sigmoidoscopy or colonoscopy referral not completed for greater than one year.
What this trial measures
- Colonoscopy uptake12 months
Preliminary effectiveness: Clinic-level proportion of participants who complete a colonoscopy
- Up-to-date CRC screening12 months
Preliminary Effectiveness: Clinic-level proportion of participants who receive any CRC screening